As of November 2024 Viking Therapeutics has 94.35M shares outstanding, a increase of 22.79% from 2023. It represents the total number of shares of a company that are owned by all its shareholders, including both public investors and company insiders.
Year | Shares outstanding | Change |
---|---|---|
2023 | 94.35M | 22.79% |
2022 | 76.83M | -0.47% |
2021 | 77.20M | 6.34% |
2020 | 72.60M | - |